Get updates on drug lawsuits, settlements and PAL news
Drug Coupon Use Soars, Prompting Safety and Spending Concerns (Bloomberg)
Article by Anna Edney, Oct 28, 2010, noting how drug coupon use has grown significantly, threatening to drive up health care costs. More ...
Coupon Study Could Drag FDA into Drug Pricing, Regulatory Change Possible
By Alaina Busch, InsideHealthReform, Jan. 20, 2011. PAL Director Wells Wilkinson interviewed on FDA authority to regulate drug coupons. More ...
Drug makers agree to $125M settlement
Lawyers USA | 03/13/2008
Eleven pharmaceutical corporations have agreed to pay $125 million to settle allegations that they deliberately inflated average wholesale prices on Medicare Part B drugs. More ...
Price of Prescriptions Tough to Swallow
ABC News | 03/26/2008
We need to stop treating prescription drugs like shampoo and fabric softener," said Alex Sugerman-Brozan, the director of the Prescription Access Litigation Project. "These are not just consumer products, they're medical treatments." More ...
Bracing for a Showdown
Drug Topics | 02/11/2008
Average manufacturer price is dead, or is it? Two months after a Federal District Court Judge granted a temporary restraining order, preventing the Centers for Medicare and Medicaid Services from implementing the new generic drug reimbursement model for Medicaid, the future of the reimbursement plan remains up in the air. Still, while it is unclear how or when the case will be resolved, most pharmacy experts agree that pharmacists will continue to see tightening in prescription drug reimbursement. More ...
Diet drug debuting with big splash
Post Gazette | 06/08/2007
Yesterday, a consumer coalition, Prescription Access Litigation, criticized GSK for making the drug available over the counter because of its side effects, which the group said include diarrhea, oily stools and flatulence. More ...
Don't Swallow the Hype
NY Daily News | 06/13/2007
"But willpower questions aside, the side effects are often intolerable. Orlistat's requisite diet is low-fat because unabsorbed fat can result in frequent, greasy stools and diarrhea that may become uncontrollable.
That's why part of the FDA's lack of concern for potential consumer abuse is that a user overdosing on Alli won't make the same mistake twice. But it's still bound to happen, which is one reason consumer watchdog Prescription Access Litigation just awarded Alli their infamous Bitter Pill Award ("With 'allies' like this, who needs enemas?" hoots PAL)." More ...
A bitter pill for slimmers?
Guardian | 09/25/2007
"The additional weight loss people have on this drug is quite minimal and this only lasts as long as they're on it," says Alex Sugarman-Brozan, director of the US consumer group, Prescription Access Litigation (Pal). "This isn't the kind of drug people are supposed to take once and then stop taking. I think GlaxoSmithKlein is hoping and anticipating that people who aren't disgusted by the side-effects will take it on an ongoing basis." More ...
3 Drug Makers Are Convicted in Reimbursement Overcharges
Bloomberg News | 04/15/2008